(Q3)Jul 31, 2022 | (Q2)Apr 30, 2022 | (Q1)Jan 31, 2022 | (FY)Oct 31, 2021 | (Q4)Oct 31, 2021 | (Q3)Jul 31, 2021 | (Q2)Apr 30, 2021 | (Q1)Jan 31, 2021 | (FY)Oct 31, 2020 | (Q2)Aug 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 82.69%-99.04K | -404.43%-372.29K | 31.56%64.74K | 29.57%-885.3K | -288.6K | -572.1K | -73.81K | 49.21K | -1.26M | -167.04K |
Net income from continuing operations | -574.23%-146.61K | -43.81%-1.02M | 112.34%41.42K | 86.72%-3.79M | ---2.72M | ---21.75K | ---708.89K | ---335.75K | ---28.54M | --79.3K |
Operating gains losses | ---- | ---- | ---- | -112.81%-154.09K | --241.17K | ---392.1K | --30.59K | ---33.75K | ---72.41K | ---148.15K |
Depreciation and amortization | -73.21%20.47K | -72.54%20.78K | -72.09%20.93K | 196.30%312.73K | --85.63K | --76.42K | --75.69K | --74.98K | --105.54K | ---- |
Asset impairment expenditure | ---- | ---- | ---- | 17,671.18%1.81M | ---- | ---- | ---- | ---- | --10.21K | ---- |
Remuneration paid in stock | ---- | ---- | ---- | ---11.34K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | --0 | ---- | ---- | -98.93%250.64K | --0 | --33.61K | ---- | ---- | --23.44M | ---- |
Other non cashItems | -87.37%9.53K | -86.65%15.4K | -72.62%28.53K | -90.74%373.18K | --78.2K | --75.42K | --115.35K | --104.2K | --4.03M | ---- |
Change In working capital | 103.23%11.11K | 73.06%339.93K | -110.91%-26.14K | 238.93%319.64K | --227.4K | ---343.71K | --196.42K | --239.52K | ---230.07K | ---98.2K |
-Change in receivables | 166.62%27.33K | 16,438.18%18.19K | 61.23%35.96K | -275.85%-170.52K | ---151.91K | ---41.03K | --110 | --22.3K | --96.97K | ---4.76K |
-Change in inventory | 116.91%1.51K | 3,654.73%34.51K | -852.18%-26.74K | 742.26%46.95K | --51.41K | ---8.93K | --919 | --3.56K | ---7.31K | ---- |
-Change in prepaid assets | -98.60%675 | -97.27%1.28K | -97.36%2.17K | 212.95%232.26K | --54.85K | --48.35K | --46.9K | --82.15K | ---205.62K | ---24.68K |
-Change in payables and accrued expense | 94.62%-18.41K | 92.57%285.96K | -128.53%-37.52K | 284.87%210.95K | --273.05K | ---342.1K | --148.49K | --131.51K | ---114.11K | ---68.76K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 82.69%-99.04K | -404.43%-372.29K | 31.56%64.74K | 29.57%-885.3K | ---288.6K | ---572.1K | ---73.81K | --49.21K | ---1.26M | ---167.04K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -91.60%17.51K | 312.69K | -9.04K | -50.85%138.12K | -70.3K | 208.42K | 281.04K | |||
Net PPE purchase and sale | ---- | ---- | ---- | ---9.02K | ---- | ---- | ---- | ---- | ---- | ---- |
Net business purchase and sale | --0 | ---- | ---- | 237.53%147.13K | ---61.28K | --208.42K | ---- | ---- | --43.59K | ---- |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --237.45K | ---- |
Net other investing changes | ---- | ---8.47K | ---9.04K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -91.60%17.51K | --312.69K | ---9.04K | -50.85%138.12K | ---70.3K | --208.42K | --0 | --0 | --281.04K | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -135.31%-25.73K | -63.89%179.8K | -40.22K | -54.15%534.36K | -36.38K | 72.87K | 497.87K | 0 | 1.17M | 0 |
Net issuance payments of debt | -135.31%-25.73K | ---15.02K | ---40.22K | 28.49%36.49K | ---36.38K | --72.87K | ---- | ---- | --28.4K | --0 |
Net common stock issuance | --0 | ---- | ---- | -56.22%497.87K | --0 | --0 | ---- | ---- | --1.14M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -135.31%-25.73K | -63.89%179.8K | ---40.22K | -54.15%534.36K | ---36.38K | --72.87K | --497.87K | --0 | --1.17M | --0 |
Net cash flow | ||||||||||
Beginning cash position | -89.11%77.93K | -68.12%94.24K | -43.16%131.7K | 238.02%231.7K | --421.74K | --715.78K | --295.59K | --231.7K | --68.55K | --193.25K |
Current changes in cash | 63.12%-107.26K | -71.66%120.2K | -68.55%15.48K | -212.29%-212.83K | ---395.28K | ---290.82K | --424.06K | --49.21K | --189.53K | ---167.04K |
Effect of exchange rate changes | 3,813.56%119.69K | -3,425.54%-136.51K | -460.40%-52.93K | 527.75%112.82K | --105.23K | ---3.22K | ---3.87K | --14.69K | ---26.38K | ---- |
End cash Position | -78.57%90.36K | -89.11%77.93K | -68.12%94.24K | -43.16%131.7K | --131.7K | --421.74K | --715.78K | --295.59K | --231.7K | --26.21K |
Free cash from | 82.69%-99.04K | -404.43%-372.29K | 31.56%64.74K | 28.86%-894.32K | ---297.62K | ---572.1K | ---73.81K | --49.21K | ---1.26M | ---167.04K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data